Hearing Tian Liangwei's words, Xu Yun was stunned subconsciously.
But soon, he nodded calmly:
"That's right."
Xu Yun's answer was within Tian Liangwei's expectation. After all, the commercial value of fifth-generation imidacloprid is there, and even StarCraft players can see its prospects.
Then Tian Liangwei thought about it, motioned Xu Yun to sit down, and said:
"So Xiao Xu, do you have any ideas about the company's preparations?"
Xu Yun didn't say anything after hearing this. He picked up the tea cup and took a sip, then looked at his teacher.
A few seconds passed.
They both laughed at the same time.
Xu Yun smiled while pouring a cup of tea for Tian Liangwei and said:
“Teacher, don’t forget, HKUST still holds 30% of the patent rights for the fifth-generation imidacloprid.
The school will not give up on me, and I cannot leave our school.
So don’t test me and just tell me what the school’s plans are.”
As a member of the University of Science and Technology for nearly 20 years, Xu Yun’s feelings for the University of Science and Technology naturally needless to say.
Non-vegetation, ruthless Practice makes perfect?
Even though he later left his job and went to work, his relationship remained with HKUST, and he would go back to school during holidays to visit his teachers and classmates.
At the same time, from a rational perspective, HKUST is undoubtedly an excellent partner.
Xu Yun's current situation is that he has technology but lacks funds.
Of course.
Funds here refer to big money.
For example, he has more than 60,000 yuan saved over the years in his Alipay, but under the current circumstances, 60,000 yuan can basically not make much trouble.
Therefore, his only option is to find institutional cooperation.
It is either official or private, or even overseas institutions, or some vampire-like venture capital or private equity funds.
Among all the alternatives, HKUST is superior to others in almost every aspect.
First of all, HKUST is backed by the Academy of Sciences, which has many top academician-level talents.
Regardless of status or background, he can be called a local giant.
Secondly, HKUST has rich experience in corporate investment and management. It has multiple direct investment institutions under its name and its business territory is vast.
Of course.
HKUST is not the only one doing this when universities engage in industry; almost all colleges and universities at home and abroad are currently taking this path.
For example, the famous Harvard even established an alumni investment fund to directly purchase private equity bonds.
Stanford University has established a number of venture capital institutions, investing in more than 300 projects a year.
In recent years, it has covered the country of stealing, and it is estimated that it will touch the mainland in a while.
It can be said that today's colleges and universities are no longer the academic-only places that many people think of.
After all, many people cannot afford to make a living by only engaging in academics. In the future, the positioning of universities will be a mature industry-university-research module. This is an inevitable trend.
For example, Shuimu is currently a shareholder of 14 listed companies, and the market values of 000938 and 002049 under his name are more than 60 billion.
The University of Science and Technology represents a company with a market value of more than 20 billion.
This mature enterprise management system is undoubtedly a huge help to Xu Yun today - you can ask him to do scientific research, or you can ask him to write papers, but when it comes to business management, Xu Yun is completely half-baked.
The most recent example is Morishita Pharmaceutical's trial a few hours ago.
Are Morishita Pharmaceutical's practices disgusting?
The answer is obvious.
But from a business perspective, it was indeed an operation that Xu Yundu admired.
And behind this kind of operation, there must be an expert who is well versed in this to give guidance.
If you ask Xu Yun to find experts of this level, you may happen to bump into one or two through the alumni circle, but it is almost impossible to organize a complete company operating system.
That being the case, why not leave this worry to others?
On the other hand, HKUST obviously does not want Xu Yun to seek cooperation with outsiders - this is like an intrusion by her husband. It is clearly his own thing, so why should he give others a share of the pie?
Both parties have related demands and emotional foundations.
Then cooperation is naturally a win-win move.
Tian Liangwei then made a phone call and communicated with someone for several minutes.
Half an hour later.
A middle-aged man in his thirties with a mustache and a suit came to the office.
Wang Qingchen took Chang Licheng to say goodbye and left.
"Xiao Xu, let me introduce you."
Tian Liangwei welcomed the middle-aged man into the office and introduced:
"This is Mr. Zheng Zu, the general person in charge of investment at HKUST and the secretary-general of HKUST New Venture Fund."
Xu Yun shook hands with Zheng Zuyi politely:
"Hello, Secretary-General Zheng."
As a veteran who has been at HKUST for many years, Xu Yun has naturally heard of Zheng Zu’s name.
Generally speaking.
The general person in charge of a fund is often the chairman, and the secretary-general is the full-time auxiliary core.
However, university funds are different. The chairman of a university venture capital fund is usually a school director who serves as a business card, and the actual person in charge is the secretary-general.
As the saying goes, everyone carries the sedan chair. Xu Yun was so polite, and Zheng Zu naturally seemed very enthusiastic:
"Hello, hello, I've heard about Xu Shen's name for a long time. When I saw him today, he was really a young man with extraordinary talent. He was only eight months old when he climbed Daidai."
He started with two lines of poetry, and the secretary-general seemed to be an old literary youth.
After the business exchange was over, Tian Liangwei first notified the insider to set his office status as not accepting customers for the time being. Then he led Xu Yun and Zheng Zu to the coffee table and started a conversation:
"Xiao Xu, Lao Zheng, since both of us have intentions, let's just decide on the framework first. What are your intentions?"
When Xu Yun heard this, he subconsciously looked at Zheng Zu and said in unison:
"I'm OK."
"very good."
Tian Liangwei nodded and said to Zheng Zu:
"Mr. Zheng, then it's up to you to introduce me."
Zheng Zu turned his body slightly to one side, put his left elbow on the armrest of the sofa, and placed his right hand on his left wrist as if to feel his pulse:
This chapter is not finished yet, please click on the next page to continue reading the exciting content! "Dr. Xu and Academician Tian, I think both of them know that the most important issue when setting up a company is the equity distribution issue.
Generally speaking, the shares held when a company is founded are divided according to the amount of investment.
For example, if the registered capital is one million, A's contribution of 300,000 will account for 30%, and B's contribution of 100,000 will account for 10%.
However, Xiao Xu, your situation is quite special, so the fund’s advice is to let you invest through technology.”
After Xu Yun listened to Zheng Zu's introduction quietly, he nodded slightly, indicating that he had no problem.
Technology investment is also called technology partner.
In real life, the biggest problem with this type of collaborator is that they may be taken seriously in the early stage, but kicked out in the later stage.
However, Xu Yun is not worried about this situation - most of the so-called "technical shares" of the kicked-out technical partners are not actually intellectual property rights in the true sense.
Real intellectual property rights are formal rights and interests protected by Article 27 of the Company Law. Especially for university incubation funds such as the HKUST New Venture Fund, the legal framework is more restrictive.
In addition, although companies under the USTC have had some disputes, these were mainly due to disagreements within the framework.
For example, in terms of personnel appointments, R&D fund allocation, etc., we have never been kicked out of the company due to technology investment.
Then Xu Yun thought for a while and said:
"Secretary-General Zheng, there is no problem with technical shares, but I also have a request."
Zheng Zu and Tian Liangwei looked at each other:
"you say."
"The product of the company we are going to build must be the fifth generation imidacloprid, right?"
"certainly."
"So if I continue to break through the inherent barriers of other technologies in the future, how should these profits be distributed?"